Notably, a vaccination strategy in the TC-1 model (HPV E7-driven cancer) was much more effective in combination with VV-IFNβ, which was dependent on the IFNβ transgene, highlighting the potential for viroimmunotherapy combinations. Here, IFNB1 is linked to cancer.